Scientists at the University of California San Diego have uncovered how genetic mutations cause a rare group of inherited ...

Scientists at the University of California San Diego have uncovered how genetic mutations cause a rare group of inherited neuromuscular disorders and identified promising new strategies to correct ...

The Manton Center works with over 3,500 patients globally who are affected by rare diseases. Brownstein, one of the study's ...

Autoimmune neuromuscular diseases may sound complex, but understanding them is the first step to getting the right care and support. Conditions such as Lambert-Eaton myasthenic syndrome (LEMS), ...

A team of researchers has developed a promising new approach to detecting neuromuscular disorders using intramuscular electromyography (iEMG). In a pilot study, the automatic diagnostic system showed ...

Sad woman sitting in front of cabinet in the dark. In a retrospective analysis, researchers characterized the prevalence and outcomes of neuropsychiatric conditions among patients hospitalized with ...

Gene editing, AI, and platform technology offer significant opportunities in neuromuscular disease research despite systemic challenges. Robert Califf, MD, highlighted the need for multidisciplinary ...

Grey's Anatomy alum Steven W. Bailey has been diagnosed with a rare neuromuscular disorder known as Congenital Myasthenia Syndrome (CMS). Bailey, 54, explained via X on Friday, January 2, that he has ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Burn Boot Camp and the Muscular Dystrophy Association (MDA) announced the results of the annual “Be Their Muscle” campaign. Together, members, franchise partners, and communities across the country ...

Bailey, 54, explained via X on Friday, January 2, that he has “spent years being cautious, private, and quiet” about something that has been “shaping [his] life and [his] work.” “That time is over,” ...

June 7 (Reuters) - FibroGen Inc FGEN.O said on Wednesday its drug to treat a type of neuromuscular disorder failed to meet the main goal in a late-stage study, sending the company's shares down about ...